Drug Delivery Devices - Malaysia
Malaysia- In Malaysia, revenue in the Drug Delivery Devices market market is projected to reach US$57.26m in 2025.
- This revenue is anticipated to exhibit an annual growth rate (CAGR 2025-2029) of 6.36%, leading to a market volume of US$73.28m by 2029.
- In a global context, the majority of revenue will be generated the United States, with a figure of US$15.64bn in 2025.
- In Malaysia, the increasing prevalence of chronic diseases is driving innovation and demand for advanced drug delivery devices within the medical technology sector.
Definition:
The Drug Delivery Devices market encompasses medical devices and systems designed for the targeted delivery and controlled release of pharmaceutical substances into the body. This market includes a wide range of devices such as inhalers, transdermal patches, infusion pumps, prefilled syringes, and drug-eluting stents. It is important to note that the market does not include the pharmaceutical products themselves but focuses on the technologies and devices used to administer these drugs effectively.
Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.
Key players in the market include Medtronic, Beckton, Dickinson & Co., and Janssen Pharmaceuticals. Further information on the key players can be found in the Market Shares boxes.
- Drug delivery systems and devices (e.g., inhalers, transdermal patches, infusion pumps, prefilled syringes)
- Implantable drug delivery devices (e.g., drug-eluting stents, implantable infusion pumps)
- Needle-free drug delivery technologies
- Pharmaceutical drugs
- Supplements and nutraceuticals
- Manual administration methods (e.g., standard syringes, oral tablets without specialized delivery systems)
